News

The Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics (TCT) 2013 offers many new insights about the latest cardiovascular technologies and treatment techniques. These...

intravascular imaging ffr ultrasound ivus optical coherence tomography oct cath

In an expert consensus document e-published in Catheterization and Cardiovascular Interventions (CCI), the Society for Cardiovascular Angiography and Interventions (...

OCT st. jude imaging systems cath lab advanced visualization ilumiens

St. Jude Medical Inc. announced the U.S. Food and Drug Administration (FDA) approval and launch of its Ilumien Optis PCI optimization system, a new technology designed to provide physicians with a...

Avinger Inc. has received CE Mark approval for Pantheris – a system that combines directional atherectomy capabilities with real-time intravascular visualization to remove plaque from blocked...

St. Jude Medical gained CE mark approval of its Ilumien Optis percutaneous coronary intervention (PCI) optimization system to better visualize stent planning and navigation. The system integrates...

December 26, 2012 — St. Jude Medical Inc. announced the first patient enrollment in its ILUMIEN I clinical study. The observational study is designed to show the optimal way optical coherence...

Volcano Corporation announced that it has entered into a definitive agreement to acquire Sync-Rx Ltd., a privately-held company based in Israel that develops advanced software applications that...

Avinger Ocelot OCT CTO catheter

The U.S. Food and Drug Administration (FDA) has granted market clearance for the Avinger Inc. Ocelot optical coherenace tomography (OCT) catheter to help cross...

CONNECT II Clinical Trial CTO Crossing Catherter Peripheral Artery Disease

Avinger Inc., a medical device manufacturer of multi-functional catheters for crossing CTOs in patients with...

July 20, 2012 — The ability to see inside the arteries of vascular disease patients in high resolution before and during stenting procedures can offer valuable information. A new study of...

July 5, 2012 — Avinger Inc., a medical device manufacturer of multifunctional catheters, announced in June that it has successfully completed enrollment in its CONNECT II global clinical trial.

June 8, 2012 — Austin Heart announced its participation in CONNECT II, a global clinical trial that gives physicians access to a new imaging technology...

April 23, 2012 - Abbott and St. Jude Medical announced ChoiceAlliance, a multi-year joint initiative that provides mutual U.S. customers access to a robust portfolio of interventional cardiology,...

March 9, 2012 — Avinger Inc. announced the enrollment of the first U.S. patient in the CONNECT II global clinical trial evaluating the safety and efficacy of Ocelot. The device is the first...

Avinger Inc. announced the enrollment of the first European patient in the CONNECT II global clinical trial. The first patient was enrolled by Dr. Bernhard Reimers at Ospedale di Mirano in Mirano...

October 26, 2011 – St. Jude Medical announced it has received U.S. Food and Drug Administration (FDA) clearance for its Ilumien system, the first integrated diagnostic technology that combines...

October 21, 2011 – St. Jude Medical announced the launch of the C7-XR optical coherence tomography (OCT) intravascular imaging system with the C7 Dragonfly Imaging Catheter in India. OCT is a next...

June 30, 2011 — The MemorialCare Heart and Vascular Institute (MHVI) at Long Beach Memorial has acquired the C7-XR OCT intravascular imaging system from St. Jude Medical. It is an imaging technology...
June 1, 2011 – If at first you don’t succeed, try, try again. That is what St. Jude Medical is doing after one court rejected its claims that Volcano Corp. developed an optical coherence tomography (...
May 18, 2011 – The world’s first system to integrate the functional and anatomical modalities of fractional flow reserve (FFR) and optical coherence tomography (OCT) into one platform will be...

January 31, 2011 – Volcano Corp. said today the Superior Court of Massachusetts issued a decision ruling in favor of Volcano and its subsidiary Axsun Technologies Inc., and against LightLab...

January 4, 2010 – The U.S. Food and Drug Administration (FDA) has released an update of what medical devices it expects to be developed and brought to market within the next 10 years.

October 7, 2010 – The Superior Court of Massachusetts has ruled against LightLab Imaging in the company’s optical coherence tomography (OCT) trade secret case against Volcano and its wholly owned...

September 22, 2010 - A new intravascular imaging system will be highlighted at the annual Transcatheter Cardiovascular Therapeutics (TCT) meeting in Washington, D.C. The C7-XR optical coherence...

September 15, 2010 – A high-definition intravascular ultrasound (IVUS) system will be demonstrated during the Transcatheter Cardiovascular Therapeutics (TCT) 2010 symposium Sept. 21-25 in...

September 1, 2010 - The results of follow-up tests undertaken ten years after the first patient was treated with a Cypher sirolimus-eluting coronary stent were presented at the European Society of...

August 24, 2010 – Optical coherence tomography (OCT) evaluation of a patient with anterior ST-elevation myocardial infarction (STEMI) who received two OrbusNeich Genous Bio-engineered R stents...

August 11, 2010 – Development of an optical coherence tomography (OCT) imaging system built into an angioplasty balloon is described in the journal Review of Scientific Instruments,...

July 28, 2010 – This week St. Jude Medical filed a patent infringement lawsuit against Volcano Corp. over its fractional flow reserve (FFR) wires. The suit was filed in federal district court in...

June 3, 2010 – Six-month data from the first 45 patients enrolled in the second stage of a trial for a bioresorbable stent demonstrated strong results. Abbott's bioresorbable vascular scaffold (...

May 24, 2010 – New intravascular imaging innovations, such as registered angiography and intravascular ultrasound (IVUS), forward-looking IVUS and a combined IVUS/balloon catheter will be...

May 21, 2010 – A second company is hoping to gain U.S. Food and Drug Administration (FDA) clearance for an optical coherence tomography (OCT) intravascular imaging system. Volcano Corp. said its...

May 20, 2010 – St. Jude Medical Inc. announced yesterday it is purchasing LightLab Imaging Inc. for $90 million. Lightlab makes optical coherence tomography (OCT) intravascular imaging systems....

May 6, 2010 – After entered the Japanese drug-eluting stent market earlier this year, Abbott's Xience V and Boston Scientific's Promus stents picked up share from competitors Medtronic and Cordis...

May 5, 2010 – A new high-definition intravascular imaging system gained U.S. Food and Drug Administration (FDA) clearance today. LightLab Imaging Inc. said its C7-XR optical coherence tomography (...

April 21, 2010 – Nearly 50 percent of survey respondents said they would adopt optical coherence tomography (OCT) intravascular imaging systems when they become available in the United States. The...

March 29, 2010 - Optical coherence tomography (OCT) not only has the potential to identify vulnerable plaques, but in countries like Japan, it is already a standard follow up to stenting...

March 8, 2010 – A self-expanding and disconnectable stent today gained CE mark approval in Europe to treat acute coronary syndrome (ACS).

February 22, 2010 – During the Joint Interventional Meeting (JIM) Feb. 11-13 in Rome, the Cappella Sideguard 3.25 bifucation stent was highlighted.

January 6, 2010 – European CE mark clearance was granted this week for the Volcano OCT (optical coherence tomography) imaging system and catheter. Volcano said its OCT system will be commercially...

November 6, 2009 – Nearly 4 million people nationwide suffer from cardiac arrhythmias each year, according to the 2006 U.S. Cardiac Rhythm Management Market report by Frost and Sullivan. About 2.5...

September 18, 2009 ¬– Abbott has announced the company's schedule of key news announcements and events during the Transcatheter Cardiovascular Therapeutics (TCT) 2009 conference in San Francisco,...

August 21, 2009 – The Cardiovascular Rearch Foundation, the sponsor of the Transcatheter Cardiovascular Therapeutics (TCT) symposium, will feature a series of featured clinical trials in addition...

July 9, 2009 - Volcano Corporation said yesterday it signed a termination agreement with its largest distributor in Japan, Goodman Company Ltd., enabling Volcano to accelerate its transition to a...

June 1, 2009 - Six months after placement of a vProtect Luminal Shield to treat a "vulnerable plaque,” a follow-up exam revealed reduced plaque burden and reduced stenosis in the target vessel.

May 21, 2009 - LightLab Imaging Inc. this week is launching its next generation optical coherence tomography (OCT) system, the C7XR FD-OCT Imaging System with the C7 Dragonfly Imaging Catheter, at...

January 6, 2009 - LightLab Imaging Inc. said the number of clinical intravascular optical coherence tomography (OCT) procedures using the company's OCT systems has surpassed 10,000.

OCT is...

December 30, 2008 - Volcano Corp. will acquire Axsun Technologies Inc., a developer and manufacturer of lasers and optical engines used in medical Optical Coherence Tomography (OCT) imaging...

December 23, 2008 - Volcano Corp., a manufacturer of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it has entered into a definitive agreement...

October 20, 2008 – At TCT last week Abbott announced two-year data from 30 patients in its ABSORB clinical trial, demonstrating its bioabsorbable drug eluting stent successfully treated coronary...

October 12, 2008 – Research results indicate that optical coherence tomography (OCT) may be the best tool available to detect vulnerable plaque (VP) in coronary arteries, according to findings...

May 8, 2008 – The first human procedure using the Volcano OCT imaging catheter, which uses optical coherence tomography (OCT) designed to enhance the diagnosis and treatment of coronary and...

January 22, 2008 - A new stent with a nanothin surface application shows promise in opening and healing blocked heart arteries without the life-threatening dangers of thrombosis and heart attack...

January 22, 2008 - A new stent with a nanothin surface application known as Polyzene-F shows promise in opening and healing blocked heart arteries reportedly without the potential risks of...

April 3, 2007 —FoxHollow Technologies Inc. has announced it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration for its NightHawk Plaque Excision System. The...